ResearcherUniversity of Southern CaliforniaNo recent work listed

Weikun Xiao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3434-7961; OpenAlex author ID A5051576877. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2022: 2 papers

Papers 2

Matrix stiffness mediates pancreatic cancer chemoresistance through induction of exosome hypersecretion in a cancer associated fibroblasts-tumor organoid biomi… Co-author DOI 10.1016/j.mbplus.2022.100111 ↗
Cancer-Associated Fibroblasts Confer Gemcitabine Resistance to Pancreatic Cancer Cells through PTEN-Targeting miRNAs in Exosomes. First author DOI 10.3390/cancers14112812 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Reginald Hill · 2 shared papers, 2022 · strength 0.41
- Paper Cancer-Associated Fibroblasts Confer Gemcitabine Resistance to Pancreatic Cancer Cells through PTEN-Targeting miRNAs in… DOI 10.3390/cancers14112812 ↗
- Paper Matrix stiffness mediates pancreatic cancer chemoresistance through induction of exosome hypersecretion in a cancer ass… DOI 10.1016/j.mbplus.2022.100111 ↗
Katherine E. Richards · 1 shared paper, 2022 · strength 0.26
- Paper Cancer-Associated Fibroblasts Confer Gemcitabine Resistance to Pancreatic Cancer Cells through PTEN-Targeting miRNAs in… DOI 10.3390/cancers14112812 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.